alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
NIOSH Program Update

Stuart Hinnefeld

Director

National Institute for Occupational Safety and Health

Division of Compensation Analysis and Support

March 2013

Augusta, GA
Program News

 DCAS updates

• Personnel• Budget
Overall Initial Claim Informati

(as of February 28, 2013)

 38,946 cases have been referred to NIOSH fo

reconstruction (DR)

 36,859 (95%) cases have been returned to DO

• Cases submitted with a DR report 32,

• Cases currently pulled from DR by DOL 1,

• Cases currently pulled from DR for SEC 3,

 1,445 (3%) cases remain at NIOSH for dose

reconstruction

 642 (2%) cases were administratively closed
Overview of Active Cases

(as of February 28, 2013)

 Of the 1,445 cases remaining at NIOSH for d

reconstruction:

• 322 cases in the dose reconstruction process

• 211 initial draft dose reconstruction reports in th

of claimants, and NIOSH awaiting the return of t1 form

• 912 cases in development to begin the dose

reconstruction
Summary of PoCs for Comple

Dose Reconstructions

(as of February 28, 2013)

 Of the 32,335 dose reconstructions sent bac

DOL for final adjudication:

• 9,274 cases had a PoC (probability of causation)

• 23,061 cases had a PoC < 50%
Submittals vs. Production

(as of December 31, 2012)
Status of First 5,000 Claims

(as of February 28, 2013)

 4,863 claims at DOL

• 267 pulled for DOL issues

• 390 pulled for SEC

• 4,206 submitted with DR

 118 claims at NIOSH

• 81 administratively closed• 10 DRs with claimants (DOL reworks/reinstated wit

year)

• 12 DRs in process (DOL reworks/reinstated within p

• 15 gathering information

 19 claim numbers deleted
Status of First 10,000 Claim

(as of February 28, 2013)

 9,768 claims at DOL

• 444 pulled for DOL issues

• 1,017 pulled for SEC

• 8,307 submitted with DR

 202 claims at NIOSH

• 149 administratively closed• 11 DRs with claimants (1 initial; 10 DOL reworks wi

year)

• 26 DRs in process (3 initial; 23 DOL reworks within 

• 16 gathering information

 30 claim numbers deleted
DOE Response to Requests

for Exposure Records

(as of February 28, 2013)

 Number of outstanding requests 298

 Outstanding requests > 60 days 56
Special Exposure Cohort Summ

(as of March 2013)

 Petitions received  Petitions in qualification process  Petitions qualified for evaluation 

• NIOSH evaluation in progress 0

• NIOSH evaluation completed 128

– SEC Evaluation Reports

with the Advisory Board

for recommendation 2

 Petitions not qualifying for evaluation 

* Petitions not qualifying include 5 petitions received prior to the rule 

final and Petition 34 where the site was de‐listed.
Special Exposure Cohort Summa

(as of March 2013)

 99 SEC classes have been added since May 2

• 56 (55%) through the 83.13 process• 43 (45%) through the 83.14 process

 18 SEC classes have been denied since May 

 The added classes represent classes of work

70 sites
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 98-1634

In Re: MICHAEL D. WILKINS,

Petitioner.

On Petition for Writ of Mandamus.

(BK-95-33189-T)

Submitted: July 2, 1998 Decided: July 22, 1998

Before NIEMEYER and HAMILTON, Circuit Judges, and HALL, Senior

Circuit Judge.

Petition denied by unpublished per curiam opinion.

Michael D. Wilkins, Petitioner Pro Se.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2

PER CURIAM:

Michael D. Wilkins has filed a petition for a writ of mandamus, asking this court to order (1) a federal magistrate judge to

decide whether Wilkins’ civil rights were violated during the

course of bankruptcy proceedings; (2) the United States Attorney to

investigate his claims; and (3) the bankruptcy trustee to secure

property that should be a part of the bankruptcy proceedings.

Mandamus is a drastic remedy to be used only in extraordinary

circumstances. See Kerr v. United States Dist. Court, 426 U.S. 394,

402 (1976). Mandamus relief is only available when there are no

other means by which the relief sought could be granted, see In re

Beard, 811 F.2d 818, 826 (4th Cir. 1987), and may not be used as a

substitute for appeal. See In re United Steelworkers, 595 F.2d 958,

960 (4th Cir. 1979). The party seeking mandamus relief carries the

heavy burden of showing that he has “no other adequate means to

attain the relief he desires” and that his right to such relief is

“clear and indisputable.” Allied Chem. Corp. v. Daiflon, Inc., 449

U.S. 33, 35 (1980). Wilkins has not made such a showing. Accordingly, we deny the petition for a writ of mandamus. We also deny Wilkins’ motion for judicial redress and dispense with oral argument

because the facts and legal contentions are adequately presented in

the materials before the court and argument would not aid the

decisional process.

PETITION DENIED
POTENTIAL REVIEW TARGETS

ACCURACY AND/OR CONSISTENCY

AT ONE SITE OR MULTIPLE SITES?

UTILIZATION OF ALL AVAILABLE 

INFORMATION?

FOCUS ON “SIGNIFICANT” EXPOSURES 

INDEPENDENT EVALUATIONS OR 

INCORPORATED IN CURRENT CASE 

REVIEWS
POTENTIAL REVIEW TARGETS 2

EXPAND PROCEDURE REVIEWS? 

REQUIRE TIMELINES? 

USE OF CATI INFORMATION 

HOW TO HANDLE INCIDENTS –

CONSISTENCY OF APPROACH AND USE OF 

AVAILABLE DATA
POTENTIAL REVIEW TARGETS 3

ASSIGNMENT OF COWORKER DOSE TO 

INDIVIDUALS

LOCATION OF SKIN CANCERS

USE OF IN-VITROAND/OR IN-VIVO DATA

ASSIGNMENT OF WORK TITLE 

ASSIGNMENT OF GLOVEBOX 

CORRECTION FACTOR

CONSISTENCY OF APPROACH ACROSS 

MULTIPLE AWE SITES
POTENTIAL REVIEW TARGETS 4

ASSIGNMENT OF EXPOSURE AREA

SITE ASSIGNMENT (OAK RIDGE)

ASSIGNMENT OF MISSED DOSE

HANDLING DISCREPANCIES IN 

MONITORING DATA

RESIDUAL CONTAMINATION

ASSIGNMENT OF PERCENTILES
**UN PUBLISHED** 

UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

**No. 12** 

**- 6002** 

JORGE GALEAS, JR., a/k/a Jorge Gevara
,

Plaintiff

- Appellant
,

v.
FNU BYRD, Chaplain, Lanesboro Correctional Institution
,

Defendant

- Appellee

.

Appeal from the United States District Court for the Western District of North Carolina , at Charlotte

. Robert J. Conrad, Jr., Chief District Judge. ( 3:11

- cv

- 00543

- RJC )

Submitted : March 15, 2012 Decided: March 20, 2 012

Before DUNCAN and FLOYD , Circuit Judges, and HAMILTON, Senior Circuit Judge.

Affirmed by un published per curiam opinion

.

Jorge Galeas, Jr., Appellant Pro Se.

Unpublished opinions are not binding precedent in this circuit.2 PER CURIAM :

Jorge Galeas, Jr., appeals the district court’s order

dismissing his 42 U.S.C. § 1983 (2006) complaint under 28 U.S.C.

§ 1915A(b) (1) (2006) as malicious

. We have reviewed the record

and find no reversible error. Accordingly, we affirm for the

reason s stated by the district court. Galeas v. FNU Byrd
,

No. 3:11

- cv

- 00543

- RJC (W.D.N.C. Dec. 20, 2011)

. We dispense

with oral argument because the facts and legal contentions are

adequately presented in the materials before the court and

argument would not a id the decisional process.

AFFIRMED
AGENDA

Advisory Board on Radiation and Worker Health 

Teleconference Meeting of the

Subcommittee on Dose Reconstruction Review

February 10, 2016

Conference Call Number: 1-866-659-0537

Participant Pass Code: 9933701

10:30 a.m. Eastern Time

Welcome and roll-call

DISCUSSION

Review and Discussion of Draft Report to DHHS Secretary (attached)

1. Resolution of two issues remaining from discussion at 12/1/15 meeting:

• Finalize decision on Allied blind case

• Determine nr of cases whose compensability changed as a result of 

dose reconstruction review discussion

2. Review Second Draft Report to DHHS Secretary revised based on 12/1/15 

Subcommittee mtg.

3. Blinds at DCAS (Calhoun) and from Set 22 (Gogliotti)

4. Discuss assigning a new set of blinds to SC&A (Katz)

5. Possible Recommendations to Board for changes in DRR process going 

forward

• Criteria for assigning Findings/Observations (Calhoun)

• Changes or additions in recording/assessing impact of Findings

• Changes in presentation of DRR process at DRSC meetings

-- SC&A proposal (Gogliotti)

6. Case Reviews Issue Resolution for Sets 14-21 (if time permits)

5:00 p.m. Adjourn
Exhibit


EXHIBIT 10.27


SUMMARY OF DIRECTOR COMPENSATION
OF
AMERIGAS PROPANE, INC. 
(the General Partner of AmeriGas Partners, L.P.)


The table below shows the components of director compensation effective October 1, 2015.  A director who is an officer or employee of the Registrant or its subsidiaries is not compensated for service on the Board of Directors or on any Committee of the Board.  


DIRECTORS’ COMPENSATION




CASH        EQUITY
COMPONENT        COMPONENT 


		
	Annual Retainer
	$65,000        1,500 Phantom Units 


(Representing 
AmeriGas Partners, L.P.
Common Units to be
awarded in January 2016).


Annual Retainer for            $165,000
Non-Executive Chairman(1) 


Additional Annual Retainer for
Audit Committee Members 
(other than the Chairperson)         $20,000


Additional Annual Retainer for 
Audit Committee Chairperson        $25,000


Additional Annual Retainer for         
Corporate Governance
Committee Chairperson              $  7,500


Additional Annual Retainer for
Compensation/Pension Committee
Chairperson                $  7,500


Additional Annual Retainer for
Presiding Director                $15,000


The Directors are also offered employee rates on propane purchases. 


		
	(1)
	Mr. Greenberg will not receive any equity compensation for his services as Non-Executive Chairman.
Exhibit 32.2    CERTIFICATION PURSUANT TO18 U.S.C. Section 1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002   In connection with the Quarterly Report ofCyber Supply Inc.(the "Company") onForm 10-Q for the period ended August 31, 2011as filed with the Securities and Exchange Commission on the date here of (the "report"), I,Romain Gay-Crosier, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:  (1)        The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and  (2)        The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.   Dated this 6th day of October, 2011.  ROMAIN GAY-CROSIERRomain Gay-Crosier,Chief Financial Officer
              A signed original of these written statements required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of thiswritten statement required by Section 906, has been provided to Cyber Supply Inc. and will be retained by Cyber Supply Inc. and furnished to the Securities and Exchange Commission or its staff upon request.


---
EXHIBIT 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, E. G. Marchi, President of Global NuTech, Inc. (the "Company"), hereby
certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

     (i)  the Quarterly Report on Form 10-Q/A of the Company, for the quarter
          ended March 31, 2010, and to which this certification is attached as
          Exhibit 32.1 (the "Report") fully complies with the requirements of
          Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as
          amended; and

     (ii) the information contained in the Report fairly presents, in all
          material respects, the financial condition and results of operations
          of the Company.


                                     By: /s/ E. G. Marchi
                                        ---------------------------------------
                                     Name:  E. G. Marchi
                                     Title: President
                                            (Principal Executive Officer)

                                     Date:  January 10, 2011

A signed original of this written statement required by Section 906 of the
Sarbanes-Oxley Act of 2002 has been provided to the Registrant and will be
retained by the Registrant and furnished to the Securities and Exchange
Commission or its staff upon request.
Exhibit 13.1





CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




In connection with the Annual Report of Eltek Ltd. (the “Company”) on Form 20-F for the period ending December 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Arieh Reichart, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:





(1)           The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2)           The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.








/s/ Arieh Reichart*


Arieh Reichart


President and Chief Executive Officer





May 13, 2010





*           The originally executed copy of this Certification will be maintained at the Company’s offices and will be made available for inspection upon request.
**EXHIBIT 31.2**

 

**CHIEF FINANCIAL OFFICER CERTIFICATION UNDER SECTION 302 OF THE**

**SARBANES-OXLEY ACT**

 

I, James D. Constantine, Executive Vice President and Chief Financial and Administrative Officer of Factory Card & Party Outlet Corp., certify that: 

 

1.  I have reviewed this annual report Form 10-K of Factory Card & Party Outlet Corp; 

 

2.  Based on my knowledge, this report does not contain any untruestatement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this annual report;

 

3.  Based on my knowledge, the financial statementsand other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report; 

 

4.  The Registrant’s other certifying officer and I areresponsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Registrant and have: 

 

a)  Designed such disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in whichthis report is being prepared; 

 

b)  Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of theperiod in which this report is being prepared; 

 

c)  Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter that has materially affected, or is reasonably likelyto materially affect, the Registrant’s internal control over financial reporting; and 

 

5.  The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the auditcommittee of Registrant’s board of directors: 

 

a)  all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process,summarize and report financial information; and 

 

b)  any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting. 

 

Date: April 14, 2004
IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF FLORIDA

TALLAHASSEE DIVISION

UNITED STATES OF AMERICA

v. CASE NO.: 4:11cr24-SPM

CORNELIUS THOMPSON

Defendant.

____________________________/

ACCEPTANCE OF GUILTY PLEA

Pursuant to the Report and Recommendation of the United States

Magistrate Judge, to which there have been no timely objections, and subject to

the Court’s consideration of any Plea Agreement pursuant to Fed. R. Crim. P.

11(e)(2), the plea of guilty of the defendant, CORNELIUS THOMPSON, to

Counts One, Two, Three, and Four of the indictment is hereby ACCEPTED. All

parties shall appear before this Court for sentencing as directed.

DONE AND ORDERED this 25th day of April, 2011.

s/ Stephan P. Mickle 

Stephan P. Mickle

Chief United States District Judge

Case 4:11-cr-00024-RH-WCS Document 29 Filed 04/25/11 Page 1 of 1
[Federal Register Volume 73, Number 20 (Wednesday, January 30, 2008)]
[Notices]
[Page 5572]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-388]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Notice of Meetings

    In accordance with section 10(d) of the Federal Advisory Committee 
Act as amended (5 U.S.C., Appendix 2), the Agency for Healthcare 
Research and Quality (AHRQ) announces meetings of scientific peer 
review groups. The subcommittees listed below are part of the Agency's 
Health Services Research Initial Review Group Committee.
    The subcommittee meetings will be closed to the public in 
accordance with the Federal Advisory Committee Act, section 10(d) of 5 
U.S.C., Appendix 2 and 5 U.S.C. 552b(c)(6). Grant applications are to 
be reviewed and discussed at these meetings. These discussions are 
likely to involve information concerning individuals associated with 
the applications, including assessments of their personal 
qualifications to conduct their proposed projects. This information is 
exempt from mandatory disclosure under the above-cited statutes.
    1. Name of Subcommittee: Health Care Quality and Effectiveness 
Research.
    Date: February 26, 2008 (Open from 8 a.m. to 8:15 a.m. on February 
26 and closed for remainder of the meeting).
    Place: Agency for Healthcare Research and Quality (AHRQ). John 
Eisenberg Conference Center, 540 Gaither Road, Rockville, Maryland 
20850.
    2. Name of Subcommittee: Health Care Technology and Decision 
Sciences.
    Date: February 28, 2008 (Open from 8 a.m. to 8:15 a.m. on February 
28 and closed for remainder of the meeting).
    Place: Agency for Healthcare Research and Quality (AHRQ). John 
Eisenberg Conference Center, 540 Gaither Road, Rockville, Maryland 
20850.
    3. Name of Subcommittee: Health Care Research Training.
    Date: March 6-7, 2008 (Open from 9 a.m. to 9:15 a.m. on March 6 and 
closed for remainder of the meeting).
    Place: Agency for Healthcare Research and Quality (AHRQ). John 
Eisenberg Conference Center, 540 Gaither Road, Rockville, Maryland 
20850.
    4. Name of Subcommittee: Health Systems Research.
    Date: March 6, 2008 (Open from 8 a.m. to 8:15 a.m. on March 6 and 
closed for remainder of the meeting).
    Place: Agency for Healthcare Research and Quality (AHRQ). John 
Eisenberg Conference Center, 540 Gaither Road, Rockville, Maryland 
20850.
    Contact Person: Anyone wishing to obtain a roster of members, 
agenda or minutes of the nonconfidential portions of the meetings 
should contact Mrs. Bonnie Campbell, Committee Management Officer, 
Office of Extramural Research, Education and Priority Populations, 
AHRQ, 540 Gaither Road, Suite 2000, Rockville, Maryland 20850, 
Telephone (301) 427-1554.
    Agenda items for these meetings are subject to change as priorities 
dictate.

    Dated: January 22, 2008.
Carolyn M. Clancy,
Director.
[FR Doc. 08-388 Filed 1-29-08; 8:45 am]
BILLING CODE 4160-90-M
AGENDA 

Advisory Board on Radiation and Worker Health 

Teleconference Meeting of the 

Weldon Spring Work Group 

September 10, 2012 

Conference Call Number: 1-866-659-0537 

Participant Pass Code: 9933701 

1:00 p.m. (Eastern Time) Welcome and roll-call/introductions 

Work Group Discussion 

• Thorium processing (DCAS white paper) 

• Raffinate pits (SC&A memorandum) 

• Petitioner comments 

• Summary and WG report to the Board 

Adjourn
Exhibit 32.2

                    CERTIFICATION OF CHIEF FINANCIAL OFFICER
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Maven Media Holdings Inc. (the
"Company") on Form 10-Q for the period ending September 30, 2008 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I,
Adrienne Humphreys, Chief Financial Officer of the Company, certify, pursuant to
18 U.S.C. ss.1350, as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of
2002, that:

     (1)  The Report fully complies with the requirements of section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and result of operations of
          the Company.

IN WITNESS WHEREOF, the undersigned has executed this certification as of the
6th day of November, 2008.


/s/ Adrienne Humphreys
------------------------------
Chief Financial Officer